CYTOKINETICS, INCORPORATED (CYTK) Operating income 2016–2025
CYTOKINETICS, INCORPORATED (CYTK) annual operating income history from SEC filings — each fiscal year as reported.
-$612.3MFY2025 · since FY2016: $18.7M → -$612.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$612.3M | -14.2% |
| FY2024 | -$536.2M | -8.1% |
| FY2023 | -$496.2M | -53.1% |
| FY2022 | -$324.2M | -74.0% |
| FY2021 | -$186.3M | -98.3% |
| FY2020 | -$93.9M | +5.0% |
| FY2019 | -$98.9M | -11.2% |
| FY2018 | -$88.9M | +21.6% |
| FY2017 | -$113.4M | -706.8% |
| FY2016 | $18.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CYTK financial trends
CYTK RevenueCYTK Net incomeCYTK Net marginCYTK Gross profitCYTK Gross marginCYTK Operating marginCYTK Operating cash flowCYTK Free cash flowCYTK Capital expendituresCYTK Return on equityCYTK Stock buybacksCYTK Dividends paidCYTK Total assetsCYTK Total liabilitiesCYTK Shareholders’ equityCYTK overview →